📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-23 18:02
1 analysed today
FollowTelegram
1
Today
151,860
All-time analysed
43,535
Positive
6,743
Negative
92,745
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
5 announcements match the current filters (relevance ≥ 5).
SEBI Confirms Market Ban on Nirman Agri Genetics & MD Over Alleged 93% IPO Fund Siphoning
SEBI has issued a Confirmatory Order dated August 10, 2026, upholding its earlier interim directions against Nirman Agri Genetics and its Managing Director, Pranav Kailas Bagal. The regulator highlighted prima facie findings of systematic diversion and siphoning of approximately 93% of the company's IPO proceeds through non-existent shell entities. The order restrains the company from accessing securities markets, halts corporate actions (stock split and bonus issue), and bars the MD from dealing in the company's shares. SEBI noted that the company failed to provide supporting evidence or agreements to substantiate its defense.
Confidence: HIGH
What changedSEBI confirmed its October 2025 interim restraint order against Nirman Agri Genetics and its MD after rejecting oral defenses citing lack of supporting documentary evidence.
Why it mattersConfirms serious regulatory allegations of 93% IPO fund siphoning, halts planned corporate actions, prevents capital raising, and casts doubt on the integrity of the company's past reported financial statements.
Alleged diverted IPO proceeds: approximately 93%SEBI Confirmatory Order Date: August 10, 2026Interim Order Date: October 14, 2025Delay in stock exchange disclosure: August 10, 2026 to September 23, 2026
📅 Short termSevere negative overhang on the stock as market access restrictions and the trading bar on the promoter MD remain fully in force.
📈 Long termExistential corporate governance threat pending the final SEBI investigation; frozen corporate actions and scrutiny on financial books severely impair business credibility.
⚠ Risk flags
- Regulatory debarment from capital markets
- Alleged siphoning of 93% IPO proceeds into shell entities
- Questioned authenticity of accounting entries and reported profitability
- Promoter dealing ban
Key Highlights
SEBI confirmed interim ban restraining Nirman Agri Genetics from accessing securities markets until further orders
Prima facie findings show diversion and siphoning of approximately 93% of IPO proceeds via suspect shell layers
MD Pranav Kailas Bagal restrained from buying, selling, or dealing in NAGL shares directly or indirectly
SEBI denied requests to proceed with bonus issue, stock split, and proposed company name change
Order WTM/KV/CFID/CFID-SEC2/32656/2026-27 dated August 10, 2026 confirmed directions from October 14, 2025
👀 What to Watch
Monitor final outcome of SEBI's detailed fraud investigation and any legal appeals filed by the company in SAT. Given regulatory comments regarding unverified advances and misstated accounting entries, reported financial metrics should be viewed with extreme caution.
Art Nirman Q1 Loss Widens to ₹0.19 Cr; Revenue Up 41% YoY to ₹2.11 Cr
Art Nirman reported a net loss of ₹19.51 lakhs for the quarter ended June 30, 2026, widening from a loss of ₹7.21 lakhs in the same period last year. Revenue from operations grew 41% YoY to ₹2.11 crore, though it saw a sharp sequential decline from ₹22.48 crore in the March 2026 quarter. The company is currently contesting a significant GST demand of ₹1.54 crore, which exceeds its total TTM net profit. Inventory buildup remains high with a negative inventory change of ₹12.45 crore, indicating ongoing project construction without corresponding sales recognition this quarter.
Confidence: HIGH
What changedThe company has moved from a marginal profit in the previous quarter (March 2026) to a loss, despite a year-on-year increase in top-line revenue.
Why it mattersFor a micro-cap real estate firm with high debt (D/E 1.96), consistent revenue recognition is critical to servicing finance costs and funding the planned ₹300 crore expansion.
Revenue (Q1 FY27): ₹2.11 CrNet Loss (Q1 FY27): ₹0.195 CrGST Demand under Appeal: ₹1.54 CrGST Demand vs TTM PAT: 154%Q1 Revenue vs TTM Revenue: 6.4%
📅 Short termThe stock may face pressure due to the widening YoY loss and the significant sequential drop in revenue compared to the March quarter.
📈 Long termLong-term value depends on the company's ability to convert its ₹63.59 Cr inventory into sales and successfully execute the Ahmedabad redevelopment projects using its expanded borrowing limits.
⚠ Risk flags
- Significant tax litigation (₹1.54 Cr GST demand)
- High Debt-to-Equity ratio of 1.96
- Lumpy revenue recognition typical of small-scale real estate projects
Key Highlights
Net loss widened to ₹19.51 lakhs compared to a loss of ₹7.21 lakhs in June 2025.
Revenue from operations stood at ₹2.11 crore, representing only ~6.4% of TTM revenue.
Contingent liability identified via a GST demand of ₹1.54 crore under appeal.
Inventory buildup reflected in a negative inventory change of ₹12.45 crore for the quarter.
Bank guarantees totaling ₹7.60 crore are active for redevelopment projects in Ahmedabad.
👀 What to Watch
Investors should monitor the pace of inventory monetization and the legal outcome of the ₹1.54 crore GST dispute, which is material relative to the company's annual earnings.
Art Nirman FY26 Net Profit Drops 74% to ₹52 Lakh Despite 21% Revenue Growth
Art Nirman Limited reported a 21% increase in annual revenue to ₹3,323.59 Lakh for FY26, yet net profit plummeted by 74% to ₹51.99 Lakh from ₹199.23 Lakh in FY25. The company's debt profile worsened significantly, with non-current borrowings surging over 300% to ₹7,282.24 Lakh. Q4 FY26 was particularly weak, with revenue falling to just ₹48.13 Lakh compared to ₹892.39 Lakh in the year-ago period. While inventory levels have increased to ₹7,540.64 Lakh, the sharp rise in finance costs and shrinking margins pose substantial risks.
Key Highlights
Annual Net Profit declined 73.9% YoY to ₹51.99 Lakh from ₹199.23 Lakh.
Non-current borrowings increased by 305% to ₹7,282.24 Lakh from ₹1,795.78 Lakh.
Q4 FY26 revenue collapsed to ₹48.13 Lakh from ₹892.39 Lakh in Q4 FY25.
Annual finance costs jumped significantly to ₹418.76 Lakh compared to ₹112.58 Lakh in the previous year.
Inventory levels rose to ₹7,540.64 Lakh, indicating significant capital tied up in ongoing projects.
👀 What to Watch
Investors should exercise caution as the company's profitability has crashed despite higher annual turnover, primarily due to a massive spike in debt and interest obligations. Monitor the company's ability to convert its high inventory into cash flow to service the newly added debt.
Art Nirman Q3 FY26 Net Profit Drops 95% YoY to ₹0.88 Lakh; Revenue Falls 73%
Art Nirman Limited reported a weak financial performance for the quarter ended December 31, 2025. Revenue from operations saw a sharp decline to ₹290.00 Lakh, down from ₹1075.46 Lakh in the same quarter of the previous year. Net profit plummeted to just ₹0.88 Lakh compared to ₹17.80 Lakh YoY, as high operational expenses nearly offset total income. For the nine-month period, while revenue grew slightly to ₹1846.13 Lakh, the net profit decreased to ₹121.84 Lakh from ₹149.23 Lakh in the prior year.
Key Highlights
Revenue from operations fell 73% YoY to ₹290.00 Lakh in Q3 FY26.
Net Profit for the quarter stood at a marginal ₹0.88 Lakh versus ₹17.80 Lakh in Q3 FY25.
Total expenses for the quarter reached ₹298.43 Lakh, consuming 99.7% of the total income.
9-month Net Profit declined to ₹121.84 Lakh from ₹149.23 Lakh in the previous year.
Earnings Per Share (EPS) for the quarter dropped to ₹0.003 from ₹0.069 YoY.
👀 What to Watch
Investors should exercise caution as the company's quarterly margins have significantly compressed, leading to near-zero profitability. Monitor the company's ability to manage project costs and revive revenue growth in the upcoming quarters.
Art Nirman Q3 FY26 Net Profit Falls 91% YoY to ₹6.88 Lakhs; Revenue Down 73%
Art Nirman Limited reported a weak set of numbers for the quarter ended December 31, 2025, with a significant decline in both top-line and bottom-line performance. Revenue from operations plummeted to ₹290.00 lakhs from ₹1,075.46 lakhs in the same quarter last year, representing a 73% YoY drop. Net profit followed suit, crashing 91% YoY to ₹6.88 lakhs compared to ₹77.80 lakhs in Q3 FY25. While there was a marginal sequential improvement in profit from ₹4.39 lakhs in Q2 FY26, the overall scale of operations has contracted sharply.
Key Highlights
Revenue from operations fell 73% YoY to ₹290.00 lakhs in Q3 FY26.
Net profit declined 91% YoY to ₹6.88 lakhs from ₹77.80 lakhs in the year-ago period.
Nine-month (9M) revenue stands at ₹1,816.13 lakhs, slightly lower than ₹1,846.13 lakhs in 9M FY25.
Basic and Diluted EPS for the quarter dropped to ₹0.03 from ₹0.31 YoY.
Total expenses for the quarter were ₹292.43 lakhs, with 'Other Expenses' accounting for ₹103.53 lakhs.
👀 What to Watch
Investors should exercise caution given the sharp decline in revenue and profitability, which may indicate delays in project completions or sales. It is advisable to wait for management commentary regarding the project pipeline and future revenue recognition before taking new positions.
